Our ITO™ platform designs both small and large molecule drugs across all therapeutic areas.

Our Pipeline is focused on Precision Oncology, Precision Neuroscience, and Immunology & Inflammation

Developing

Large Molecules

Therapeutic Area

AI-driven Precision
Target ID

Wet Lab
Target Validation

Novel
Hit ID

Hit to
Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering Status

1910-104

mAb/VHH Bispecific Antagonist

Large Molecule

Precision Oncology

1910-104

mAB/VHH Bispecific Antagonist

Large Molecule

Indication:

Precision Oncology

Indication

Precision Oncology

AI-driven Precision Target ID

Wet Lab Target Validation

Novel Hit ID

Hit to Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering
Status

1910-105

VHH/VHH Bispecific Antagonist

Large Molecule

Immunology & Inflammation

1910-105

VHH/VHH Bispecific Antagonist

Large Molecule

Indication:

Immunology & Inflammation

Indication

Immunology & Inflammation

AI-driven Precision Target ID

Wet Lab Target Validation

Novel Hit ID

Hit to Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering
Status

1910-106

VHH Agonist

Large Molecule

Immunology
& Inflammation

1910-106

VHH Agonist

Large Molecule

Indication:

Immunology
& Inflammation

Indication

Immunology
& Inflammation

AI-driven Precision Target ID

Wet Lab Target Validation

Novel Hit ID

Hit to Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering
Status

1910-107

VHH Antagonist

Large Molecule

Immunology & Inflammaton

1910-107

VHH Antagonist

Large Molecule

Indication:

Immunology & Inflammaton

Indication

Immunology & Inflammaton

AI-driven Precision Target ID

Wet Lab Target Validation

Novel Hit ID

Hit to Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering
Status

Partnering
Status

Out-licensing

Small Molecules

Therapeutic Area

AI-driven Precision
Target ID

Wet Lab
Target Validation

Novel
Hit ID

Hit to
Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering Status

1910-102

Covalent Inhibitor

Small Molecule

Precision Neuroscience

(Post Surgical Pain)

1910-102

Covalent Inhibitor

Small Molecule

Indication:

Precision Neuroscience

(Post Surgical Pain)

Indication

Precision Neuroscience

(Post Surgical Pain)

AI-driven Precision Target ID

Wet Lab Target Validation

Novel Hit ID

Hit to Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering
Status

Precision Neuroscience
‍
(Chemotherapy-induced Peripheral Neuropathy)

1910-102

Covalent Inhibitor

Small Molecule

Indication:

Precision Neuroscience
‍
(Chemotherapy-induced Peripheral Neuropathy)

Indication

Precision Neuroscience
‍
(Chemotherapy-induced Peripheral Neuropathy)

AI-driven Precision Target ID

Wet Lab Target Validation

Novel Hit ID

Hit to Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering
Status

Precision Neuroscience
‍
(Inflammatory Pain)

1910-102

Covalent Inhibitor

Small Molecule

Indication:

Precision Neuroscience
‍
(Inflammatory Pain)

Indication

Precision Neuroscience
‍
(Inflammatory Pain)

AI-driven Precision Target ID

Wet Lab Target Validation

Novel Hit ID

Hit to Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering
Status

Partnering
Status

1910-103

Allosteric Inhibitor

Small Molecule

Immunology & Inflammaion

1910-103

Allosteric Inhibitor

Small Molecule

Indication:

Immunology & Inflammaion

Indication

Immunology & Inflammaion

AI-driven Precision Target ID

Wet Lab Target Validation

Novel Hit ID

Hit to Lead

Lead Optimization

Development Candidate Nomination

IND-enabling Studies

Phase 1

Partnering
Status

Partnering
Status

Accelerate Your AI Drug Discovery Journey

Co-Engineering

Co-Engineering

Available Now

Collaborate with 1910 at the level of data, AI models, optimized compute and interactive tools (e.g., dashboards, conversational chatbots) to engineer bespoke small or large molecule discovery modules that you can use in your organization.

Partner with us

Partner with us

Fill out the form to explore how we can work together.

Company

First Name

Last Name

Email

Phone

Message

Submit Message

Submit Message

Company

First Name

Last Name

Email

Phone

Message

Sumbit Message

Sumbit Message

Oops! Something went wrong while submitting the form.

Message sent successfully

Thanks for reaching out. Our team has received your message and will be in touch shortly.

Or if you prefer, you can contact us directly at

bd@1910.ai

Copy to clipboard

This website uses cookies to ensure you get the best experience.

This website uses 
cookies to ensure you
get the best experience.

Accept cookies

Accept cookies